Patient Information:
	•Name: Mindy Oates
	•Date of Birth: 06/25/1980
	•Medical Record Number: M1016
	•Date of Admission: 01/12/2022
	•Date of Discharge: 02/15/2022
	•Attending Physician: Dr. Charles Egan
	•Primary Diagnosis: Colorectal Cancer (Stage III)

Reason for Admission:
	Mindy Oates was admitted to the hospital due to persistent lower abdominal pain and rectal bleeding that had worsened over a two-week period. Upon initial assessment, a thorough physical examination revealed abnormalities in his abdomen, and laboratory tests indicated anemia. A subsequent colonoscopy confirmed the presence of a large tumor in the sigmoid colon. Further imaging scans (CT scan and MRI) were conducted to evaluate the extent of the cancer and determine whether it had spread to other organs.

Medical History:
	Mindy Oates has a history of hypertension, which he has been managing with medication for the past ten years. He was diagnosed with type 2 diabetes three years ago and is currently on insulin therapy. John also suffers from chronic obstructive pulmonary disease (COPD), for which he uses an inhaler regularly. He underwent a left nephrectomy seven years ago due to renal cell carcinoma. He has no known allergies, and before admission, he was taking Atenolol 50mg once daily, Metformin 1000mg twice daily, Insulin Glargine 60 units at bedtime, and Salmeterol/Fluticasone inhaler as needed.

Diagnostic Findings:
	Pathology reports confirmed the presence of adenocarcinoma in the sigmoid colon. The CT scan and MRI revealed that the tumor had invaded into nearby tissues and lymph nodes but had not spread to distant organs, making it Stage III colorectal cancer. Blood tests showed increased levels of carcinoembryonic antigen (CEA) and lactate dehydrogenase (LDH), indicative of malignancy.

Treatment Plan:
	A multidisciplinary team developed a comprehensive treatment plan for Mindy Oates, which included a sigmoid colectomy followed by a temporary loop ileostomy. Post-operative care involved managing his pain and preventing complications such as infection and blood clots. He was scheduled to undergo six cycles of FOLFOX (oxaliplatin, leucovorin, fluorouracil) chemotherapy. Radiation therapy was not deemed necessary due to the absence of distant metastasis.

Hospital Course:
	Mindy Oates's surgical intervention was successful, and he recovered well from the surgery. However, he faced challenges during his hospital stay, including anemia requiring blood transfusions and episodes of nausea and vomiting due to chemotherapy. A team of specialists, including surgeons, oncologists, and nutritionists, worked together to manage his disease and support his recovery.

Follow-Up Plan:
	Mindy Oates will be scheduled for follow-up appointments every three months for the first year, then every six months thereafter. He will continue taking Metformin and Insulin Glargine as prescribed by his endocrinologist, while adjusting his hypertension medication under the supervision of his primary care physician. John has been advised to maintain a low-fiber diet and avoid foods that may cause discomfort related to his ileostomy. He should also monitor for signs of complications such as dehydration, electrolyte imbalances, and skin irritation around the stoma site.

Patient Education:
	Mindy Oates and his family were educated on post-surgical care, including instructions on managing the ileal conduit, recognizing signs of complications such as obstruction or peristomal leakage, and managing common side effects like diarrhea, abdominal pain, and fatigue. They were also advised to contact their healthcare provider immediately if they experience any warning signs, such as fever, persistent pain, or changes in stool consistency.

Discharge Instructions:
	Mindy Oates was provided with detailed discharge instructions to ensure his continued recovery and health maintenance. These included medication adherence guidelines, wound care practices, hydration recommendations, and physical activity guidelines. He was also given information on resources for emotional support and financial assistance during his recovery.

Prognosis and Long-Term Outlook:
	The prognosis for Mindy Oates is favorable due to the removal of the tumor and the completion of chemotherapy. However, regular monitoring for early detection of recurrence and managing ongoing health issues will be crucial in ensuring his long-term survival.

Final Remarks:
	Dr. Charles Egan commends Mindy Oates on his resilience throughout the treatment journey and his cooperation during the various stages of his care. She emphasizes the importance of continued adherence to the follow-up plan, medication regimen, and lifestyle recommendations for optimal outcomes. Both Dr. Egan and Mindy Oates sign this report as validation of its content on February 15, 2022.
